Table 5

Linear GEE regression comparing mean diabetes care measurements in pre versus during pandemic period among KPGA adult members with prevalent diabetes, 2018–2021

Diabetes care processPrepandemic (2018–2019)During pandemic (2020–2021)Absolute change
(during vs pre)
Mean difference (95% CI)*
HbA1c (mean; %)7.2 (1.7)7.4 (1.7)+0.110.13 (0.11, 0.15)
Systolic BP (mean (SD); mm Hg)132.4 (12.2)133.9 (12.5)+1.581.22 (1.08, 1.35)
Diastolic BP (mean (SD); mm Hg)72.4 (8.7)72.3 (9.2)−0.090.41 (0.32, 0.49)
LDL cholesterol (mean (SD); mg/dL)101.3 (41.9)92.4 (36.6)−8.86−7.77 (−8.32, −7.23)
Creatinine (mean (SD); mg/dL)1.1 (0.7)1.1 (0.8)+0.020.01 (0.00, 0.01)
OR (95% CI)
UACR (% >300 mg/g)†6.59.4+2.91.47 (1.35,1.60)
  • Missingness: Prepandemic: HbA1c=6.7%; BP=1.7%; cholesterol=19.0%; creatinine=7.0%; UACR=31.8%. During pandemic: HbA1c=8.2%; BP=13.2%; cholesterol=26.8%; creatinine=6.3%; UACR=39.4%.

  • *Compares during versus pre period, adjusted for baseline age; a 95% CI that does not include 0 is significant.

  • †UACR was highly skewed and thus we compared the proportion of those with high risk of kidney disease (UACR>300 mg/g) pre and during the pandemic and reported OR (95% CI) adjusted for baseline age.

  • BP, blood pressure; GEE, generalized estimating equation; KPGA, Kaiser Permanente Georgia; LDL, low-density lipoprotein; UACR, urine-albumin-creatinine ratio.